Global Heart Valve Devices Market size was valued at USD 11,942.26 Million in 2025 and is expected to reach USD 31,553.91 Million by 2034 at a CAGR of 11.4% during the forecast period 2025 – 2034.
Heart Valve Devices Market Overview
The heart valve devices market includes the development, production, and distribution of medical devices designed to repair or replace damaged heart valves, which address conditions such as aortic stenosis and mitral regurgitation. These devices include mechanical, biological, and transcatheter valves that are ready to meet the needs of the patient.
The market is mainly inspired by the increasing proliferation of heart diseases globally. Factors contribute to this trend, such as changing lifestyles and increasing rates of chronic conditions such as high blood pressure, obesity, and diabetes.
For example, the American Heart Association Journal reports that the most common congenital cardiovascular abnormality, Bicuspid aortic valve (BAV), affects the population of 1% to 2%. As the occurrence of heart disorders increases, the demand for effective treatment options increases the heart valve device market growth.
An important challenge in the market is the high cost of building heart valve devices. These devices require advanced materials, sophisticated manufacturing processes, and stringent quality control to meet safety and efficacy standards.
Materials such as titanium or special polymers are expensive, and the accuracy required to match the exact patient specifications increases technical and labor costs. Comprehensive testing and clinical trials further add total costs, making these tools expensive for both manufacturers and patients, which hinders market growth.
The development of innovative material for heart valve replacement presents a transformational opportunity. Innovative materials like biocompatible polymers, bioengineered tissue, and synthetic composites are bringing a change in heart valve devices techniques by reducing rejection rates and better mimicking natural hemodynamic flow.
These progressions address previous issues such as the need for lifelong anticoagulation therapy in patients with mechanical valves.
Depending on the treatment, the heart valve device market is divided into heart valve replacement devices and heart valve repair devices. In 2024, the heart valve replacement device segment dominated the market, inspired by a significant increase in valve replacement surgery and auxiliary health reimbursement.
Physicians often consider transcatheter valve-in-valve devices as a better therapy for tissue heart valve replacement patients, which apply to the aorta, mitral, tricuspid, and pulmonary valves. Technological progress in the heart valve replacement device further leads to the growth of this segment.
Based on Region, the market is segmented into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. North America dominated the market and is expected to keep its dominance during the forecast period.
This growth is driven by the growing acceptance of technically advanced products and processes in the field. Transcatheter valves offer a suitable option for traditional surgical aortic valve replacement in some pediatric patients who are sub-regional candidates. The relatively high average selling price of heart valve devices in North America supports market development.
Many major players are actively contributing to the development of heart valve devices through innovative product launches and strategic acquisitions. In May 2024, the Edwards Lifesciences Company announced the use of advanced Rizilia tissue technology for expanded durability for the Sapien 3 Ultra Risilia Valve, a transcatheter aortic heart valve in Europe.
These developments are expected; they expect to increase market growth during the forecast period by offering advanced solutions that face existing challenges in heart valve treatment.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 11,942.26 Million |
| Projected Market Size in 2034 | USD 31,553.91 Million |
| Market Size in 2024 | USD 10,720.16 Million |
| CAGR Growth Rate | 11.4% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product Type, Treatment, End-User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
CMI has comprehensively analyzed Global Heart valve devices market. The drivers, restraints, challenges, opportunities, key trends have been explained in depth to depict in depth scenario of Heart valve devices market. Segment wise market size and market share for Heart valve devices during the forecast period are duly addressed to portray the probable picture of the Global Heart valve devices industry.
The competitive landscape includes of key innovators, market giants as well as niche players are studied and analyzed extensively with respect to their strengths, weaknesses as well as value addition prospects. In addition, the report covers Heart valve devices key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.
List of the prominent players in the Heart Valve Devices Market:
- Medtronic plc
- Boston Scientific Corporation
- Edwards Lifesciences
- Abbott Cardiovascular
- Foldax Inc.
- Novostia SA
- Meril Life Sciences Pvt. Ltd.
- Corcym
- Anteris Technologies Ltd
- Artivion
- Thubrikar Aortic Valve Inc.
- Biosensors International Group Ltd.
- MicroPort Scientific Corporation
- Braile Biomedica
- TTK Healthcare Limited
- Colibri Heart Valve
- CryoLife Inc.
- NeoVasc
- Micro Interventional Devices Incorporated
- XELTIS
- Others
The Heart Valve Devices Market is segmented as follows:
By Product Type
- Mechanical Heart Valves
- Biological Heart Valves
- Transcatheter Heart Valves
By Treatment
- Valve Repair
- Valve Replacement
By End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America